Clinical Trial

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry

Study acronym: MYVAL-TAX-TAVR
Recruiting
View on ClinicalTrials.gov →
Summary
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-02.
Status change: Not Yet Recruiting → Recruiting 2025-01-02
Trial Details
NCT Number NCT06493994
Lead Sponsor University of Luebeck
Collaborators: University Hopsital Schleswig Holstein Campus Lübeck
Conditions Aortic Valve Stenosis
Enrollment 100 participants
Start Date 2025-01-01
Primary Completion 2027-01-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-03